Bellaire, TX, United States of America

Jiaxin Liu


Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2000-2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Jiaxin Liu in Leukemia Research

Introduction

Jiaxin Liu is an accomplished inventor based in Bellaire, Texas, known for her significant contributions to leukemia research. With a total of two patents, her work focuses on innovative methods for detecting and quantifying BCR-ABL gene products, which are crucial in understanding Philadelphia chromosome-positive leukemic cells.

Latest Patents

Jiaxin Liu's latest patents include groundbreaking inventions aimed at inhibiting cell growth stimulated by the Philadelphia chromosome. One patent provides methods for detecting and quantifying BCR-ABL gene products, allowing for the assessment of tumor burden in patients. This invention also aids in determining specific phases of leukemia, particularly chronic-phase chronic myeloid leukemia (CML). Another patent discloses compositions comprising peptides that bind to molecules involved in BCR-ABL oncoprotein function. These peptides inhibit BCR-ABL oncoprotein activation, thereby blocking oncogenic signals and inducing cell death in leukemia cells expressing the oncoprotein. Additionally, methods for processing bone marrow using these peptide compositions are provided, which can enrich stem cells for Philadelphia chromosome-negative cells prior to transplantation.

Career Highlights

Jiaxin Liu is affiliated with the University of Texas System, where she continues her research and development in the field of leukemia treatment. Her innovative approaches have the potential to significantly impact patient outcomes and advance the understanding of leukemia biology.

Collaborations

Jiaxin Liu has collaborated with notable colleagues, including Ralph B. Arlinghaus and Dai Lu, who contribute to her research efforts in leukemia.

Conclusion

Jiaxin Liu's innovative work in leukemia research exemplifies the importance of scientific advancements in improving patient care. Her patents reflect a commitment to developing effective treatments for leukemia, showcasing her role as a leading inventor in this critical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…